+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Healthcare Contract Development & Manufacturing Organization Market - Global Forecast 2026-2032- Product Image
Healthcare Contract Development & Manufacturing Organization Market - Global Forecast 2026-2032- Product Image
New

Healthcare Contract Development & Manufacturing Organization Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 187 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 5456956
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Healthcare Contract Development & Manufacturing Organization Market is experiencing transformative growth, catalyzed by shifting regulatory demands, increasing complexity in therapeutic development, and intensified competition. Senior decision-makers are under pressure to optimize operations and foster resilient partnerships to sustain performance in this evolving environment.

Market Snapshot: Healthcare Contract Development & Manufacturing Organization Market

The Healthcare Contract Development & Manufacturing Organization Market advanced from USD 360.38 billion in 2025 to USD 391.77 billion in 2026, and is projected to attain USD 668.80 billion by 2032, reflecting a CAGR of 9.23%. This robust trajectory highlights the sector’s essential role in bridging pharmaceutical and biotechnology innovation with scalable, compliant production. As companies strive to bring new treatments to global markets efficiently, the market’s expansion demonstrates its relevance in supporting rapid therapeutic innovation and accommodating continuous changes in healthcare delivery models and product pipelines.

Scope & Segmentation of the Study

  • Service Offerings: Includes contract development such as clinical and preclinical support, regulatory strategy, and process optimization, as well as contract manufacturing involving API, finished dosage, medical device production, packaging, and labeling.
  • Molecule Types: Covers both large molecules (including monoclonal antibodies, vaccines, recombinant proteins) and small molecules, reflecting a wide array of client needs and project complexity.
  • Dosage Forms: Encompasses liquid, semi-solid, and solid formulations, engineered to accommodate varied commercial and clinical protocols.
  • Applications: Supports patented and generic drug production, as well as medical devices, serving to extend treatment reach and accelerate innovation cycles.
  • Therapeutic Areas: Serves cardiology, immunology, infectious diseases, metabolic disorders, neurology, and oncology, allowing organizations to address high-impact health challenges.
  • End Users: Partners with pharmaceutical companies, biotech firms, generic drug manufacturers, medical device organizations, and academic or research institutions, underpinning broad industry engagement.
  • Regions: Encompasses Americas, Europe, Middle East & Africa, and Asia-Pacific, reflecting diverse regulatory environments, investment climates, and operational nuances across each geography.
  • Technologies: Applies advanced biologics, digital manufacturing solutions, AI-driven process design, continuous manufacturing, and systems focused on sustainability.

Key Takeaways for Senior Decision-Makers

  • CDMO collaborations have evolved beyond transactional support to become strategic alliances, enabling improved risk management and shortened product launch cycles.
  • Personalized medicine and biologics are prompting a shift toward flexible production infrastructures, as modular and adaptable facility designs support evolving therapeutic modalities.
  • Integration of artificial intelligence, digital twins, and cloud-based ecosystems is reshaping pharmaceutical and device development by improving efficiency and adaptability.
  • Organizations are increasingly required to address regulatory harmony and heightened sustainability demands, fostering investment in compliance systems and greener technologies.
  • Distinct regional trends present both established manufacturing centers and emerging innovation hubs, requiring decision-makers to strategically align supply chains and partnerships in multifaceted environments.
  • Ongoing enhancements in process technology and a priority on agile talent development position firms to seize new opportunities and respond to rapidly shifting client requirements.

Tariff Impact: Navigating Policy Change in the U.S. Market

New U.S. tariffs effective 2025 will affect a spectrum of imported chemicals, intermediates, and packaging materials. The resulting sourcing complexity introduces potential cost increases and longer lead times for CDMOs that rely on global supply chains. Senior executives are adjusting procurement frameworks, exploring nearshoring, and leveraging tariff engineering strategies to minimize exposure and support sustainable production continuity in client services.

Methodology & Data Sources

This analysis draws on structured interviews with industry leaders, process experts, and regulators, supported by quantitative client surveys. Secondary research incorporates industry publications, regulatory filings, proprietary databases, and peer validation. Rigorous triangulation ensures data reliability and actionable insights specific to the Healthcare Contract Development & Manufacturing Organization Market.

Why This Report Matters

  • Enables senior leaders to benchmark strategic initiatives, evaluate emerging risks, and redefine operational frameworks in a fast-evolving market.
  • Presents tangible growth avenues and partnership models, assisting organizations to adapt effectively to regulatory and policy developments.
  • Offers guidance for implementing compliant, sustainable, and technology-optimized decisions across regional and global healthcare operations.

Conclusion

The Healthcare Contract Development & Manufacturing Organization Market stands at a pivotal point where technological advancement, regulatory alignment, and robust partnerships will influence sector outcomes. Equipped with clear insights, senior leaders are prepared to navigate ongoing change and capture emerging opportunities.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Healthcare Contract Development & Manufacturing Organization Market, by Service Offering
8.1. Contract Development Services
8.1.1. Clinical Development
8.1.1.1. Clinical Trials Support
8.1.1.2. Regulatory Support
8.1.2. Preclinical Development
8.1.2.1. In Vitro & In Vivo Studies
8.1.2.2. Toxicology Studies
8.1.3. Process Development
8.2. Contract Manufacturing Services
8.2.1. API Manufacturing
8.2.2. Finished Dosage Form Manufacturing (FDF)
8.2.3. Medical Device Manufacturing
8.2.4. Packaging & Labeling
9. Healthcare Contract Development & Manufacturing Organization Market, by Molecule Type
9.1. Large Molecules
9.1.1. Monoclonal Antibodies
9.1.2. Recombinant Proteins
9.1.3. Vaccines
9.2. Small Molecules
10. Healthcare Contract Development & Manufacturing Organization Market, by Dosage Form
10.1. Liquid Dosage Forms
10.2. Semi-Solid Dosage Forms
10.3. Solid Dosage Forms
11. Healthcare Contract Development & Manufacturing Organization Market, by Application
11.1. Generic Drugs
11.2. Medical Devices
11.3. Patented Drugs
12. Healthcare Contract Development & Manufacturing Organization Market, by Therapeutic Area
12.1. Cardiology
12.2. Immunology
12.3. Infectious Disease
12.4. Metabolic Disorders
12.5. Neurology
12.6. Oncology
13. Healthcare Contract Development & Manufacturing Organization Market, by End User
13.1. Academic & Research Institutions
13.2. Biotechnology Companies
13.3. Generic Drug Manufacturers
13.4. Medical Device Companies
13.5. Pharmaceutical Companies
13.5.1. Big Pharmaceutical Companies
13.5.2. Small & Medium-sized Pharmaceutical Companies
14. Healthcare Contract Development & Manufacturing Organization Market, by Region
14.1. Americas
14.1.1. North America
14.1.2. Latin America
14.2. Europe, Middle East & Africa
14.2.1. Europe
14.2.2. Middle East
14.2.3. Africa
14.3. Asia-Pacific
15. Healthcare Contract Development & Manufacturing Organization Market, by Group
15.1. ASEAN
15.2. GCC
15.3. European Union
15.4. BRICS
15.5. G7
15.6. NATO
16. Healthcare Contract Development & Manufacturing Organization Market, by Country
16.1. United States
16.2. Canada
16.3. Mexico
16.4. Brazil
16.5. United Kingdom
16.6. Germany
16.7. France
16.8. Russia
16.9. Italy
16.10. Spain
16.11. China
16.12. India
16.13. Japan
16.14. Australia
16.15. South Korea
17. United States Healthcare Contract Development & Manufacturing Organization Market
18. China Healthcare Contract Development & Manufacturing Organization Market
19. Competitive Landscape
19.1. Market Concentration Analysis, 2025
19.1.1. Concentration Ratio (CR)
19.1.2. Herfindahl Hirschman Index (HHI)
19.2. Recent Developments & Impact Analysis, 2025
19.3. Product Portfolio Analysis, 2025
19.4. Benchmarking Analysis, 2025
19.5. Baxter International, Inc.
19.6. Boehringer Ingelheim International GmbH
19.7. Cambrex Corporation
19.8. Catalent Inc.
19.9. Charles River Laboratories International, Inc.
19.10. Corden Pharma International GmbH
19.11. Curia Global, Inc.
19.12. Eurofins Scientific SE
19.13. EVER company group
19.14. Evonik Industries AG
19.15. FUJIFILM Diosynth Biotechnologies
19.16. Jabil, Inc.
19.17. Lonza Group AG
19.18. MedPharm Ltd.
19.19. Merck KGaA
19.20. NextPharma GmbH
19.21. Piramal Group
19.22. Porton Pharma Solutions Ltd
19.23. Recipharm AB
19.24. Samsung Biologics
19.25. Sanmina Corporation
19.26. Siegfried Holding AG
19.27. Siegfried-Group
19.28. Thermo Fisher Scientific, Inc.
19.29. WuXi AppTec
List of Figures
FIGURE 1. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SERVICE OFFERING, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY MOLECULE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY DOSAGE FORM, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY THERAPEUTIC AREA, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 13. UNITED STATES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 14. CHINA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SERVICE OFFERING, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT DEVELOPMENT SERVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT DEVELOPMENT SERVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT DEVELOPMENT SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT DEVELOPMENT SERVICES, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CLINICAL DEVELOPMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CLINICAL DEVELOPMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CLINICAL DEVELOPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CLINICAL DEVELOPMENT, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CLINICAL TRIALS SUPPORT, BY REGION, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CLINICAL TRIALS SUPPORT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CLINICAL TRIALS SUPPORT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY REGULATORY SUPPORT, BY REGION, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY REGULATORY SUPPORT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY REGULATORY SUPPORT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PRECLINICAL DEVELOPMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PRECLINICAL DEVELOPMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PRECLINICAL DEVELOPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PRECLINICAL DEVELOPMENT, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY IN VITRO & IN VIVO STUDIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY IN VITRO & IN VIVO STUDIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY IN VITRO & IN VIVO STUDIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY TOXICOLOGY STUDIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY TOXICOLOGY STUDIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY TOXICOLOGY STUDIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PROCESS DEVELOPMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PROCESS DEVELOPMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PROCESS DEVELOPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT MANUFACTURING SERVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT MANUFACTURING SERVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT MANUFACTURING SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT MANUFACTURING SERVICES, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY API MANUFACTURING, BY REGION, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY API MANUFACTURING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY API MANUFACTURING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY FINISHED DOSAGE FORM MANUFACTURING (FDF), BY REGION, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY FINISHED DOSAGE FORM MANUFACTURING (FDF), BY GROUP, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY FINISHED DOSAGE FORM MANUFACTURING (FDF), BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY MEDICAL DEVICE MANUFACTURING, BY REGION, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY MEDICAL DEVICE MANUFACTURING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY MEDICAL DEVICE MANUFACTURING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PACKAGING & LABELING, BY REGION, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PACKAGING & LABELING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PACKAGING & LABELING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY LARGE MOLECULES, BY REGION, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY LARGE MOLECULES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY LARGE MOLECULES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY LARGE MOLECULES, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY RECOMBINANT PROTEINS, BY REGION, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY RECOMBINANT PROTEINS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY RECOMBINANT PROTEINS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY VACCINES, BY REGION, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY VACCINES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY VACCINES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SMALL MOLECULES, BY REGION, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SMALL MOLECULES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SMALL MOLECULES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY LIQUID DOSAGE FORMS, BY REGION, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY LIQUID DOSAGE FORMS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY LIQUID DOSAGE FORMS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SEMI-SOLID DOSAGE FORMS, BY REGION, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SEMI-SOLID DOSAGE FORMS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SEMI-SOLID DOSAGE FORMS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SOLID DOSAGE FORMS, BY REGION, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SOLID DOSAGE FORMS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SOLID DOSAGE FORMS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY GENERIC DRUGS, BY REGION, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY GENERIC DRUGS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY GENERIC DRUGS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY MEDICAL DEVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY MEDICAL DEVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY MEDICAL DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PATENTED DRUGS, BY REGION, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PATENTED DRUGS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PATENTED DRUGS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CARDIOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CARDIOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY IMMUNOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY IMMUNOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY INFECTIOUS DISEASE, BY REGION, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY INFECTIOUS DISEASE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY INFECTIOUS DISEASE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY METABOLIC DISORDERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY METABOLIC DISORDERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY NEUROLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY NEUROLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY ONCOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 108. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 109. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY GENERIC DRUG MANUFACTURERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 110. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY GENERIC DRUG MANUFACTURERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 111. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY GENERIC DRUG MANUFACTURERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 112. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY MEDICAL DEVICE COMPANIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 113. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY MEDICAL DEVICE COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 114. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY MEDICAL DEVICE COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 115. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 116. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 117. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 118. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2032 (USD MILLION)
TABLE 119. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY BIG PHARMACEUTICAL COMPANIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 120. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY BIG PHARMACEUTICAL COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 121. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY BIG PHARMACEUTICAL COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 122. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SMALL & MEDIUM-SIZED PHARMACEUTICAL COMPANIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 123. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SMALL & MEDIUM-SIZED PHARMACEUTICAL COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 124. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SMALL & MEDIUM-SIZED PHARMACEUTICAL COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 125. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 126. AMERICAS HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 127. AMERICAS HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SERVICE OFFERING, 2018-2032 (USD MILLION)
TABLE 128. AMERICAS HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT DEVELOPMENT SERVICES, 2018-2032 (USD MILLION)
TABLE 129. AMERICAS HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CLINICAL DEVELOPMENT, 2018-2032 (USD MILLION)
TABLE 130. AMERICAS HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PRECLINICAL DEVELOPMENT, 2018-2032 (USD MILLION)
TABLE 131. AMERICAS HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT MANUFACTURING SERVICES, 2018-2032 (USD MILLION)
TABLE 132. AMERICAS HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 133. AMERICAS HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY LARGE MOLECULES, 2018-2032 (USD MILLION)
TABLE 134. AMERICAS HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 135. AMERICAS HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 136. AMERICAS HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 137. AMERICAS HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 138. AMERICAS HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2032 (USD MILLION)
TABLE 139. NORTH AMERICA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 140. NORTH AMERICA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SERVICE OFFERING, 2018-2032 (USD MILLION)
TABLE 141. NORTH AMERICA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT DEVELOPMENT SERVICES, 2018-2032 (USD MILLION)
TABLE 142. NORTH AMERICA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CLINICAL DEVELOPMENT, 2018-2032 (USD MILLION)
TABLE 143. NORTH AMERICA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PRECLINICAL DEVELOPMENT, 2018-2032 (USD MILLION)
TABLE 144. NORTH AMERICA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT MANUFACTURING SERVICES, 2018-2032 (USD MILLION)
TABLE 145. NORTH AMERICA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 146. NORTH AMERICA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY LARGE MOLECULES, 2018-2032 (USD MILLION)
TABLE 147. NORTH AMERICA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 148. NORTH AMERICA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 149. NORTH AMERICA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 150. NORTH AMERICA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 151. NORTH AMERICA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2032 (USD MILLION)
TABLE 152. LATIN AMERICA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 153. LATIN AMERICA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SERVICE OFFERING, 2018-2032 (USD MILLION)
TABLE 154. LATIN AMERICA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT DEVELOPMENT SERVICES, 2018-2032 (USD MILLION)
TABLE 155. LATIN AMERICA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CLINICAL DEVELOPMENT, 2018-2032 (USD MILLION)
TABLE 156. LATIN AMERICA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PRECLINICAL DEVELOPMENT, 2018-2032 (USD MILLION)
TABLE 157. LATIN AMERICA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT MANUFACTURING SERVICES, 2018-2032 (USD MILLION)
TABLE 158. LATIN AMERICA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 159. LATIN AMERICA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY LARGE MOLECULES, 2018-2032 (USD MILLION)
TABLE 160. LATIN AMERICA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 161. LATIN AMERICA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 162. LATIN AMERICA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 163. LATIN AMERICA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 164. LATIN AMERICA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2032 (USD MILLION)
TABLE 165. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 166. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SERVICE OFFERING, 2018-2032 (USD MILLION)
TABLE 167. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT DEVELOPMENT SERVICES, 2018-2032 (USD MILLION)
TABLE 168. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CLINICAL DEVELOPMENT, 2018-2032 (USD MILLION)
TABLE 169. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PRECLINICAL DEVELOPMENT, 2018-2032 (USD MILLION)
TABLE 170. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT MANUFACTURING SERVICES, 2018-2032 (USD MILLION)
TABLE 171. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 172. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY LARGE MOLECULES, 2018-2032 (USD MILLION)
TABLE 173. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 174. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 175. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 176. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 177. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2032 (USD MILLION)
TABLE 178. EUROPE HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 179. EUROPE HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SERVICE OFFERING, 2018-2032 (USD MILLION)
TABLE 180. EUROPE HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT DEVELOPMENT SERVICES, 2018-2032 (USD MILLION)
TABLE 181. EUROPE HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CLINICAL DEVELOPMENT, 2018-2032 (USD MILLION)
TABLE 182. EUROPE HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PRECLINICAL DEVELOPMENT, 2018-2032 (USD MILLION)
TABLE 183. EUROPE HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT MANUFACTURING SERVICES, 2018-2032 (USD MILLION)
TABLE 184. EUROPE HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 185. EUROPE HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY LARGE MOLECULES, 2018-2032 (USD MILLION)
TABLE 186. EUROPE HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 187. EUROPE HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 188. EUROPE HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 189. EUROPE HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 190. EUROPE HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2032 (USD MILLION)
TABLE 191. MIDDLE EAST HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 192. MIDDLE EAST HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SERVICE OFFERING, 2018-2032 (USD MILLION)
TABLE 193. MIDDLE EAST HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT DEVELOPMENT SERVICES, 2018-2032 (USD MILLION)
TABLE 194. MIDDLE EAST HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CLINICAL DEVELOPMENT, 2018-2032 (USD MILLION)
TABLE 195. MIDDLE EAST HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PRECLINICAL DEVELOPMENT, 2018-2032 (USD MILLION)
TABLE 196. MIDDLE EAST HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT MANUFACTURING SERVICES, 2018-2032 (USD MILLION)
TABLE 197. MIDDLE EAST HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 198. MIDDLE EAST HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY LARGE MOLECULES, 2018-2032 (USD MILLION)
TABLE 199. MIDDLE EAST HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 200. MIDDLE EAST HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 201. MIDDLE EAST HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 202. MIDDLE EAST HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 203. MIDDLE EAST HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2032 (USD MILLION)
TABLE 204. AFRICA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 205. AFRICA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SERVICE OFFERING, 2018-2032 (USD MILLION)
TABLE 206. AFRICA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT DEVELOPMENT SERVICES, 2018-2032 (USD MILLION)
TABLE 207. AFRICA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CLINICAL DEVELOPMENT, 2018-2032 (USD MILLION)
TABLE 208. AFRICA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PRECLINICAL DEVELOPMENT, 2018-2032 (USD MILLION)
TABLE 209. AFRICA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT MANUFACTURING SERVICES, 2018-2032 (USD MILLION)
TABLE 210. AFRICA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 211. AFRICA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY LARGE MOLECULES, 2018-2032 (USD MILLION)
TABLE 212. AFRICA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 213. AFRICA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 214. AFRICA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 215. AFRICA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 216. AFRICA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2032 (USD MILLION)
TABLE 217. ASIA-PACIFIC HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 218. ASIA-PACIFIC HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SERVICE OFFERING, 2018-2032 (USD MILLION)
TABLE 219. ASIA-PACIFIC HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT DEVELOPMENT SERVICES, 2018-2032 (USD MILLION)
TABLE 220. ASIA-PACIFIC HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CLINICAL DEVELOPMENT, 2018-2032 (USD MILLION)
TABLE 221. ASIA-PACIFIC HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PRECLINICAL DEVELOPMENT, 2018-2032 (USD MILLION)
TABLE 222. ASIA-PACIFIC HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CONTRACT MANUFACTURING SERVIC

Companies Mentioned

The key companies profiled in this Healthcare Contract Development & Manufacturing Organization market report include:
  • Baxter International, Inc.
  • Boehringer Ingelheim International GmbH
  • Cambrex Corporation
  • Catalent Inc.
  • Charles River Laboratories International, Inc.
  • Corden Pharma International GmbH
  • Curia Global, Inc.
  • Eurofins Scientific SE
  • EVER company group
  • Evonik Industries AG
  • FUJIFILM Diosynth Biotechnologies
  • Jabil, Inc.
  • Lonza Group AG
  • MedPharm Ltd.
  • Merck KGaA
  • NextPharma GmbH
  • Piramal Group
  • Porton Pharma Solutions Ltd
  • Recipharm AB
  • Samsung Biologics
  • Sanmina Corporation
  • Siegfried Holding AG
  • Siegfried-Group
  • Thermo Fisher Scientific, Inc.
  • WuXi AppTec

Table Information

Report AttributeDetails
No. of Pages187
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 391.77 Billion
Forecasted Market Value ( USD ) by 2032 $ 668.8 Billion
Compound Annual Growth Rate9.2%
Regions CoveredGlobal
No. of Companies Mentioned25

Related Topics

Related Reports

Healthcare Contract Development and Manufacturing Organization - Global Strategic Business Report - Product Image

Healthcare Contract Development and Manufacturing Organization - Global Strategic Business Report

  • Report
  • 117 Pages
  • Global
From
Healthcare Contract Development and Manufacturing Organization Market Size, Share & Trends Analysis Report by Type, Product, Service, Workflow, Therapeutic Area, End-use, and Region with Growth Forecasts, 2025-2033 - Product Image

Healthcare Contract Development and Manufacturing Organization Market Size, Share & Trends Analysis Report by Type, Product, Service, Workflow, Therapeutic Area, End-use, and Region with Growth Forecasts, 2025-2033

  • Report
  • 120 Pages
  • Global
From
Healthcare Contract Manufacturing Market - Global Forecast 2026-2032 - Product Image

Healthcare Contract Manufacturing Market - Global Forecast 2026-2032

  • Report
  • 192 Pages
  • Global
From
Pharmaceutical Contract Development & Manufacturing Market - Global Forecast 2026-2032 - Product Image

Pharmaceutical Contract Development & Manufacturing Market - Global Forecast 2026-2032

  • Report
  • 196 Pages
  • Global
From
Small Molecule Innovator Cdmo Market Report: Size, Share, Growth Drivers, Trends, Opportunities & Forecast 2025-2030 - Product Image

Small Molecule Innovator Cdmo Market Report: Size, Share, Growth Drivers, Trends, Opportunities & Forecast 2025-2030

  • Report
  • 87 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.